Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Rhythm Pharmaceuticals stock (RYTM)

Buy Rhythm Pharmaceuticals stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Rhythm Pharmaceuticals is a biotechnology business based in the US. Rhythm Pharmaceuticals shares (RYTM) are listed on the NASDAQ and all prices are listed in US Dollars. Rhythm Pharmaceuticals employs 226 staff and has a trailing 12-month revenue of around $91.9 million.

Our top picks for where to buy Rhythm Pharmaceuticals stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for Investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Rhythm Pharmaceuticals stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – RYTM. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Rhythm Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Finder Score: 3.1 / 5: ★★★★★
Stocks, ETFs
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Get up to 15 free stocks
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Rhythm Pharmaceuticals stock price (NASDAQ: RYTM)

Use our graph to track the performance of RYTM stocks over time.

Rhythm Pharmaceuticals shares at a glance

Information last updated 2024-07-21.
Latest market close$49.57
52-week range$17.34 - $53.92
50-day moving average $41.59
200-day moving average $39.02
Wall St. target price$57.22
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-4.63

Is it a good time to buy Rhythm Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Rhythm Pharmaceuticals price performance over time

Historical closes compared with the close of $49.57 from 2024-07-19

1 week (2024-07-16) -8.02%
1 month (2024-06-21) 18.39%
3 months (2024-04-23) 23.93%
6 months (2024-01-23) 17.88%
1 year (2023-07-21) 183.26%
2 years (2022-07-22) 276.67%
3 years (2021-07-23) 147.60%
5 years (2019-07-23) 141.92%

Rhythm Pharmaceuticals financials

Revenue TTM $91.9 million
Gross profit TTM $21.5 million
Return on assets TTM -56.2%
Return on equity TTM -194.69%
Profit margin -297.93%
Book value $1.01
Market Capitalization $3 billion

TTM: trailing 12 months

Rhythm Pharmaceuticals share dividends

We're not expecting Rhythm Pharmaceuticals to pay a dividend over the next 12 months.

Rhythm Pharmaceuticals share price volatility

Over the last 12 months, Rhythm Pharmaceuticals's shares have ranged in value from as little as $17.34 up to $53.92. A popular way to gauge a stock's volatility is its "beta".

RYTM.US volatility(beta: 2.04)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Rhythm Pharmaceuticals's is 2.043. This would suggest that Rhythm Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Rhythm Pharmaceuticals overview

Rhythm Pharmaceuticals, Inc. , a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S. A. S; Camurus; RareStone Group Ltd.

Frequently asked questions

What percentage of Rhythm Pharmaceuticals is owned by insiders or institutions?
Currently 0.541% of Rhythm Pharmaceuticals shares are held by insiders and 116.482% by institutions.
How many people work for Rhythm Pharmaceuticals?
Latest data suggests 226 work at Rhythm Pharmaceuticals.
When does the fiscal year end for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals's fiscal year ends in December.
Where is Rhythm Pharmaceuticals based?
Rhythm Pharmaceuticals's address is: 222 Berkeley Street, Boston, MA, United States, 02116
What is Rhythm Pharmaceuticals's ISIN number?
Rhythm Pharmaceuticals's international securities identification number is: US76243J1051
What is Rhythm Pharmaceuticals's CUSIP number?
Rhythm Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 76243J105

More guides on Finder

Ask a question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site